MMManar Magdy Mahmoud Mahmoud

Manar Magdy Mahmoud Mahmoud

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Manar Magdy Mahmoud Mahmoud has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Antimicrobial and Cytotoxic Lysolipins I–M Isolated from Streptomyces sp. P8-2B18

    by Manar Magdy Mahmoud Mahmoud, Kah Yean Lum, Yiwei Liu, Mikael Lenz Strube, Gundela Peschel, Luciano D. O. Souza, Miriam A. Rosenbaum, José M. A. Moreira, Stewart Brian Kirton, Charlotte H. Gotfredsen, et al.

    Lysolipin I ( 1 ) is a highly bioactive xanthone with strong antibacterial and cytotoxic properties. Given the limited number of lysolipin analogues, discovery of new natural lysolipin derivatives is important for understanding their structure-activity relationships. A soil-derived Streptomyces sp. P8-2B18 harbors a putative lysolipin biosynthetic gene cluster and LC-MS based metabolomic analysis revealed the production of lysolipin I along with unreported analogues. Large-scale fermentation followed by isolation led to the discovery of four new analogues, lysolipins J-M ( 2 – 5 ), the structures of which were elucidated by mass spectrometric and NMR spectroscopic data analyses. Lysolipin L features a five-membered lactam F ring, which was unprecedented in reported lysolipins. Lysolipin M has a novel skeleton, with an extra methyl (Me-36) and a glycosyl group replacing a 1,3-oxane ring in lysolipin I. While lysolipins I, J and K displayed strong activity against Staphylococcus aureus and Aspergillus flavus with MIC values ranging from 0.25 to 4 μg/mL and lysolipin L showed only moderate activities, lysolipin M was inactive (>50 μg/mL). Lysolipins I–K showed potent cytotoxic activity against prostate cancer cell lines LNCaP and C4-2B, with IC 50 values in the submicromolar range. In contrast, lysolipin L exhibited no cytotoxicity and lysolipin M exhibited substantially reduced potency. Their broad, non-selective bioactivities restricted their applicability as therapeutic agents.

  • Pepticinnamins N, O, and P, Nonribosomal Peptides from the Soil-Derived Streptomyces mirabilis P8-A2

    by Manar Magdy Mahmoud Mohamed, Maria Mahmoud Abboud, Matiss Maleckis, Luciano D. O. Souza, José M. A. Moreira, Charlotte H. Gotfredsen, Tilmann Weber, Ling Ding

    Cinnamoyl moiety containing nonribosomal peptides represented by pepticinnamin E are a growing family of natural products isolated from different Streptomyces species and possess diverse bioactivities. The soil bacterium Streptomyces mirabilis P8-A2 harbors a cryptic pepticinnamin biosynthetic gene cluster, producing azodyrecins as major products. Inactivation of the azodyrecin biosynthetic gene cluster by CRISPR-BEST base editing led to the activation and production of pepticinnamin E (1) and its analogues, pepticinnamins N, O, and P (2-4), the structures of which were determined by detailed NMR spectroscopy, HRMS data, and Marfey's reactions. These new compounds did not show a growth inhibitory effect against the LNCaP and C4-2B prostate cancer lines, respectively.